BLFS
BioLife Solutions, Inc. Healthcare - Medical Instruments & Supplies Investor Relations →
BioLife Solutions, Inc. (BLFS) closed at $18.85 as of 2026-03-20, trading 11.0% below its 200-week moving average of $21.18. This places BLFS in the extreme value zone. The stock moved further from the line this week, up from -13.2% last week. The 14-week RSI sits at 33, indicating neutral momentum.
Trading volume is running at 1.4x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.18 ratio) is neutral — neither side is clearly dominating.
Over the past 1847 weeks of data, BLFS has crossed below its 200-week moving average 23 times. On average, these episodes lasted 55 weeks. Historically, investors who bought BLFS at the start of these episodes saw an average one-year return of +65.2%.
With a market cap of $910 million, BLFS is a small-cap stock. The company generates a free cash flow yield of 1.4%. Return on equity stands at -3.4%. The stock trades at 2.4x book value.
Share count has increased 12.5% over three years, indicating dilution.
Over the past 33.2 years, a hypothetical investment of $100 in BLFS would have grown to $3, compared to $2683 for the S&P 500. BLFS has returned -9.7% annualized vs 10.4% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: BLFS vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After BLFS Crosses Below the Line?
Across 21 historical episodes, buying BLFS when it crossed below its 200-week moving average produced an average return of +15.6% after 12 months (median +0.0%), compared to +14.8% for the S&P 500 over the same periods. 45% of those episodes were profitable after one year. After 24 months, the average return was +31.7% vs +27.5% for the index.
Each line shows $100 invested at the moment BLFS crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
BLFS has crossed below its 200-week MA 23 times with an average 1-year return of +65.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Oct 1990 | Jan 1991 | 13 | 18.8% | +744.4% | -84.0% |
| Jun 1993 | Feb 2000 | 350 | 95.2% | -48.6% | -94.2% |
| Mar 2000 | Sep 2000 | 27 | 44.1% | -82.8% | -40.6% |
| Oct 2000 | Jun 2005 | 245 | 95.8% | -93.6% | +7.7% |
| Jul 2005 | Jul 2005 | 3 | 7.5% | -35.7% | +861.7% |
| Sep 2005 | Apr 2007 | 84 | 53.3% | -28.6% | +861.7% |
| Jun 2007 | Jan 2009 | 85 | 67.8% | -54.5% | +1124.0% |
| Feb 2009 | Feb 2009 | 1 | 20.9% | +42.9% | +1823.5% |
| Mar 2009 | Mar 2009 | 1 | 43.4% | +120.0% | +2592.9% |
| Apr 2009 | May 2009 | 3 | 30.8% | N/A | +1583.0% |
| Jan 2010 | Feb 2010 | 1 | 7.7% | -12.5% | +1583.0% |
| Apr 2010 | May 2010 | 6 | 31.7% | +12.5% | +1583.0% |
| Jun 2010 | Feb 2011 | 38 | 42.7% | +33.3% | +2144.0% |
| Mar 2011 | Apr 2011 | 3 | 4.7% | +25.0% | +1583.0% |
| Apr 2011 | Mar 2012 | 46 | 62.6% | N/A | +1583.0% |
| Apr 2012 | Jul 2012 | 13 | 14.5% | +385.7% | +1823.5% |
| Apr 2014 | Jul 2017 | 167 | 61.6% | -28.7% | +585.5% |
| Mar 2020 | Apr 2020 | 5 | 4.6% | +320.5% | +108.7% |
| Feb 2022 | Nov 2024 | 144 | 63.7% | +4.8% | -16.4% |
| Feb 2025 | Mar 2025 | 1 | 1.3% | +0.8% | -21.5% |
| Mar 2025 | Apr 2025 | 3 | 13.5% | N/A | -9.7% |
| May 2025 | Aug 2025 | 13 | 7.4% | N/A | -19.1% |
| Mar 2026 | Ongoing | 3+ | 13.2% | Ongoing | -5.1% |
| Average | 55 | — | +65.2% | — |
Frequently Asked Questions
Is BLFS below its 200-week moving average?
Yes. As of 2026-03-20, BioLife Solutions, Inc. (BLFS) is trading 11.0% below its 200-week moving average of $21.18. The current price is $18.85.
What is BLFS's 200-week moving average price?
BioLife Solutions, Inc.'s 200-week moving average is $21.18 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when BLFS drops below its 200-week moving average?
BLFS has crossed below its 200-week moving average 23 times in our data. On average, buying at that moment produced a one-year return of +65.2%. These dips have historically been decent entry points. These episodes lasted 55 weeks on average.
Is BLFS a good value right now?
Here's what our data says about BLFS as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 33. Free cash flow yield is 1.4%. Return on equity is -3.4%. Price-to-book is 2.4x. This is not a buy or sell recommendation — always do your own research.
How does BLFS compare to the S&P 500?
Over the past 33.2 years, $100 invested in BLFS would have grown to $3, compared to $2683 for the S&P 500. That's -9.7% annualized vs 10.4% for the index. BLFS has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20